VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $401,000 | -96.5% | 16,314 | -74.3% | 0.00% | -100.0% |
| Q3 2015 | $11,304,000 | -46.0% | 63,372 | -32.7% | 0.00% | -33.3% |
| Q2 2015 | $20,915,000 | +23.5% | 94,146 | +10.4% | 0.00% | 0.0% |
| Q1 2015 | $16,939,000 | -14.6% | 85,281 | -38.4% | 0.00% | 0.0% |
| Q4 2014 | $19,826,000 | -13.7% | 138,540 | -20.9% | 0.00% | -25.0% |
| Q3 2014 | $22,971,000 | +38.6% | 175,081 | +33.2% | 0.00% | +33.3% |
| Q2 2014 | $16,578,000 | +21.0% | 131,444 | +26.5% | 0.00% | +50.0% |
| Q1 2014 | $13,696,000 | +5.3% | 103,893 | -6.2% | 0.00% | 0.0% |
| Q4 2013 | $13,007,000 | +13.4% | 110,796 | +0.8% | 0.00% | 0.0% |
| Q3 2013 | $11,465,000 | +42.2% | 109,893 | +17.3% | 0.00% | 0.0% |
| Q2 2013 | $8,061,000 | – | 93,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |